The financing arm of
The 14-month-old startup plans to use the funds for operating capital, CEO
"The money certainly will come in handy," he said.
IBMD's licensed product is called ApertureRx System, which is based on technology developed by an Israeli doctor. It's designed to emit quick bursts of low-dose heat to make an incision in the eye.
"It's a precise way to position and remove a perfectly circular piece of tissue out of the cataract lens," Bryant said.
ApertureRx will be priced at around
"But the capital costs on those lasers are quite high, in the range of half a million dollars," he said.
IBMD is now working with vendors to look at the tooling it will need to manufacture the devices. It's also lining up seed capital from other investors.
Bryant said he worked for medical device companies for 35 years and commuted for two decades from the
"I was an airplane jockey," he said. "I've been traveling around the world doing this."
"Supporting innovative technology and additional manufacturing jobs for our state will continue to strengthen our knowledge economy," Mahoney said in a written statement.
Bryant said the site has not been selected.
"We want to stay in the Lowcountry," he said. "That's our goal."
(c)2014 The Post and Courier (Charleston, S.C.)
Visit The Post and Courier (Charleston, S.C.) at www.postandcourier.com
Distributed by MCT Information Services